THE ROLE OF THROMBOCYTOPENIA IN POSTPARTUM HEMORRHAGE: CLINICAL IMPLICATIONS
Main Article Content
Abstract
This review highlights the role of thrombocytopenia in postpartum hemorrhage (PPH), a leading cause of maternal mortality. It explains how reduced platelet counts—caused by gestational, hypertensive, immune, or coagulation disorders—impair hemostasis and increase bleeding risk during delivery. The paper emphasizes early diagnosis, continuous platelet monitoring, and multidisciplinary management to improve maternal outcomes.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Gernsheimer, T., James, A. H., & Stasi, R. (2013). How I treat thrombocytopenia in pregnancy. Blood, 121(1), 38–47.
2. Myers, B. (2012). Thrombocytopenia in pregnancy. Obstetric Medicine, 5(3), 91–96.
3. Sainio, S., Kekomäki, R., Riikonen, S., & Teramo, K. (2000). Maternal thrombocytopenia at term: a population-based study. Acta Obstetricia et Gynecologica Scandinavica, 79(9), 744–749.
4. Sibai, B. M. (2004). Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics & Gynecology, 102(1), 181–192.